Anthony Fauci, former head of the National Institute of Allergy and Infectious Diseases, is recovering at home after being hospitalized for nearly a week for West Nile virus infection. Fauci, a ...

News that Anthony Fauci, long-time former head of the National Institute of Allergy and Infectious Diseases, is recovering from a bad bout of West Nile virus fever throws a spotlight on a disease ...

WASHINGTON — The Democrats were not subtle this week about what their health care priorities are this election: protecting abortion rights, and making America feel good again. The four-day ...

A U.S. government agency said that a planned move by Johnson & Johnson to alter payment methods for some hospitals participating in a controversial drug discount program was “inconsistent ...

High-profile gene editing startup Tome Biosciences said in a legal filing Friday that it will terminate virtually its entire staff beginning Nov. 1. The Massachusetts WARN notice comes a day after ...

Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in your inbox. Happy Friday! Isa here. As a Floridian, my school year always started mid-August, so my internal ...

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and ...

I’m a doctor and epidemiologist, so you might expect me to be religious about preventative care: yearly visits to my primary care physician, that sort of thing. But I know we can’t prevent ...

Several years ago, while on a road trip, I ordered the now-discontinued spaghetti and meatballs during a pitstop at Denny’s. When the plate came out, I thought there was no way I could finish ...

The use of artificial intelligence in hospitals is ramping up so fast — and with such little transparency — that it is impossible to track how any given product is impacting the cost or ...

Buzzy gene-editing startup Tome Biosciences is floundering, just nine months after launching with $213 million in funding, according to several sources with direct knowledge of the matter.

Over a year after Pear Therapeutics filed for bankruptcy and shut down, its smartphone apps for people with substance use disorder and opioid use disorder are again available to patients.